Skip to main content
. 2023 Dec 7;2:1287508. doi: 10.3389/frtra.2023.1287508

Table 1.

Infusion details for all 34 infusions with MSC quality control metrics.

Infusion # Date of administration (month/day/year) Total cell count (million) Cell viability (%) CD73 (%) CD29 (%) CD31 (%) CD45 (%)
1 10/11/19 205 98.46 98.69 99.97 0.24 0.10
2 10/25/19 224 93.33 96.86 99.95 0.22 0.04
3 11/08/19 240 94.25 97.90 99.92 0.07 0.08
4 11/22/19 178 94.87 98.12 100.00 0.10 0.11
5 12/06/19 166 94.55 99.47 99.99 0.17 0.16
6 12/20/19 186 98.31 94.82 99.96 0.05 0.15
7 01/3/20 195 96.06 97.66 99.96 0.04 0.06
8 01/17/20 200 96.03 90.17 99.92 0.09 0.09
9 01/31/20 131 97.62 99.00 99.96 0.14 0.08
10 02/14/20 232 98.64 98.50 99.91 0.31 0.05
11 06/24/20 240 95.18 95.01 99.69 2.16 0.07
12 07/24/20 240 95.24 93.89 99.97 0.06 0.00
13 08/21/20 224 95.89 96.23 99.88 0.00 0.03
14 10/02/20 99.2a 95.38 99.62 100.00 0.00 0.04
15 10/30/20 240 95.35 97.11 99.87 0.00 0.07
16 11/13/20 240 94.50 94.99 99.73 0.20 0.00
17 12/11/20 240 98.28 98.11 99.89 0.00 0.00
18 01/08/21 240 97.66 95.87 99.90 0.00 0.02
19 02/05/21 240 98.32 92.64 99.91 0.02 0.07
20 03/05/21 211 95.65 88.89 99.87 0.00 0.00
21 04/02/21 240 96.67 83.57 84.62 2.28 0.51
22 04/30/21 240 95.63 98.21 99.89 0.02 0.15
23 05/28/21 240 96.91 95.32 99.88 0.00 0.16
24 06/25/21 182 95.00 92.04 99.40 0.02 0.05
25 07/23/21 240 99.29 99.28 99.90 0.00 0.34
26 08/20/21 240 94.53 98.63 99.91 0.00 0.24
27 09/17/21 240 98.86 94.52 100.00 0.05 0.02
28 10/15/21 240 96.49 91.01 99.87 0.02 0.05
29 11/12/21 205 96.97 97.88 99.94 0.00 0.45
30 12/10/21 240 96.30 95.52 99.86 0.00 0.24
31 01/7/22 221 98.57 99.66 99.72 0.00 0.19
32 02/23/22 240 98.95 96.37 100.00 0.00 0.85
33 03/09/22 240 96.70 98.87 100.00 0.00 0.79
34 04/29/22 205 96.94 99.52 99.97 0.00 0.19
a

Low cell-count due to cell growth. MSCs are expected to be positive for CD73 and CD29 and negative for CD45 and CD31 cell surface markers.